United Capital Financial Advisers, LLC Castle Biosciences Inc Transaction History

United Capital Financial Advisers, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$22.51 - $34.32 $7,473 - $11,394	332 Added 1.87%	18,054 $471,000
Q2 2022 Aug 11, 2022	BUY	$16.0 - $45.99 $896 - $2,575	56 Added 0.32%	17,722 $389,000
Q1 2022 May 16, 2022	BUY	$33.17 - $46.98 $961 - $1,362	29 Added 0.16%	17,666 $792,000
Q4 2021 Feb 14, 2022	BUY	$39.06 - $67.58 $7,694 - $13,313	197 Added 1.13%	17,637 $756,000
Q1 2021 May 14, 2021	SELL	$58.92 - $97.33 $685,828 - $1.13 Million	-11,640 Reduced 40.03%	17,440 $1.19 Million
Q4 2020 Feb 17, 2021	SELL	$43.6 - $73.05 $8,720 - $14,610	-200 Reduced 0.68%	29,080 $1.95 Million
Q2 2020 Aug 13, 2020	SELL	$27.28 - $43.01 $383,011 - $603,860	-14,040 Reduced 32.41%	29,280 $1.1 Million
Q1 2020 May 15, 2020	BUY	$23.08 - $35.53 $999,825 - $1.54 Million	43,320 New	43,320 $1.29 Million

172

25.5M

511K

130K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $739M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on United Capital Financial Advisers, LLC with notifications on news.